This Article Full Text Full Text (PDF) Supplemental Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meireles, S. I. Articles by Reis, L. F. L. Search for Related Content PubMed PubMed Citation Articles by Meireles, S. I. Articles by Reis, L. F. L.

Molecular Classifiers for Gastric Cancer and Nonmalignant Diseases of the Gastric Mucosa

¹ Ludwig Institute for Cancer Research and² Hospital do Câncer A.C. Camargo;³ BioInfo and Instituto de Matemática e Estatística da Universidade de São Paulo; and⁴ SENAC College of Computer Science and Technology, São Paulo, Brazil

High incidence of gastric cancer-related death is mainly due to diagnosis at an advanced stage in addition to the lack of adequate neoadjuvant therapy. Hence, new tools aimed at early diagnosis would have a positive impact in the outcome of the disease. Using cDNA arrays having 376 genes either identified previously as altered in gastric tumors or known to be altered in human cancer, we determined expression signature of 99 tissue fragments representing normal gastric mucosa, gastritis, intestinal metaplasia, and adenocarcinomas. We first validated the array by identifying molecular markers that are associated with intestinal metaplasia, considered as a transition stage of gastric adenocarcinomas of the intestinal type as well as markers that are associated with diffuse type of gastric adenocarcinomas. Next, we applied Fisher’s linear discriminant analysis in an exhaustive search of trios of genes that could be used to build classifiers for class distinction. Many classifiers could distinguish between normal and tumor samples, whereas, for the distinction of gastritis from tumor and for metaplasia from tumor, fewer classifiers were identified. Statistical validations showed that trios that discriminate between normal and tumor samples are powerful classifiers to distinguish between tumor and nontumor samples. More relevant, it was possible to identify samples of intestinal metaplasia that have expression signature resembling that of an adenocarcinoma and can now be used for follow-up of patients to determine their potential as a prognostic test for malignant transformation.

This article has been cited by other articles:

				I.-S. Song, N. S. Oh, H.-T. Kim, G.-H. Ha, S.-Y. Jeong, J.-M. Kim, D.-I. Kim, H.-S. Yoo, C.-H. Kim, and N.-S. Kim Human ZNF312b Promotes the Progression of Gastric Cancer by Transcriptional Activation of the K-ras Gene Cancer Res., April 1, 2009; 69(7): 3131 - 3139. [Abstract] [Full Text] [PDF]

				Y. Qu and S. Xu Quantitative Trait Associated Microarray Gene Expression Data Analysis Mol. Biol. Evol., August 1, 2006; 23(8): 1558 - 1573. [Abstract] [Full Text] [PDF]

				L. I. Gomes, G. H. Esteves, A. F. Carvalho, E. B. Cristo, R. Hirata Jr., W. K. Martins, S. M. Marques, L. P. Camargo, H. Brentani, A. Pelosof, et al. Expression Profile of Malignant and Nonmalignant Lesions of Esophagus and Stomach: Differential Activity of Functional Modules Related to Inflammation and Lipid Metabolism Cancer Res., August 15, 2005; 65(16): 7127 - 7136. [Abstract] [Full Text] [PDF]

				S. Y. Chui, T. M. Clay, H. K. Lyerly, and M. A. Morse The Development of Therapeutic and Preventive Vaccines for Gastric Cancer and Helicobacter pylori Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1883 - 1889. [Abstract] [Full Text] [PDF]